Cargando…

Do we need an assessment of the nutrition risk in the critically ill patient?

The description of a new score of nutrition risk in critically ill patients in the previous issue of Critical Care is very appropriate and timely. However, the use of this score will probably not help the clinician to improve the prescription of nutrition therapy, especially when major uncertainties...

Descripción completa

Detalles Bibliográficos
Autor principal:	Preiser, Jean-Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396220/ https://www.ncbi.nlm.nih.gov/pubmed/22236982 http://dx.doi.org/10.1186/cc10572

Ejemplares similares

Do we need a 6D’s Framework of Nutritional Stewardship in critical care?
por: Pisani, Dafne, et al.
Publicado: (2021)

Tight blood glucose control: a recommendation applicable to any critically ill patient?
por: Devos, Philippe, et al.
Publicado: (2004)

We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
por: Cotta, Menino Osbert, et al.
Publicado: (2016)

Tight glucose control: should we move from intensive insulin therapy alone to modulation of insulin and nutritional inputs?
por: Kalfon, Pierre, et al.
Publicado: (2008)

Optimum sedation and analgesia in critical illness: we need to keep trying
por: Lavery, Gavin G
Publicado: (2004)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Do we really need another risk prediction rule? Yes, we do
por: Lo, Alexander X., et al.
Publicado: (2022)

What do we still need to learn on digitally assessed biomarkers?
por: Acs, Balazs, et al.
Publicado: (2021)

In a search of a protective titer: Do we or do we not need to know?
por: Baranova, Ancha, et al.
Publicado: (2021)

When should we start renal-replacement therapy in critically ill patients with acute kidney injury: do we finally have the answer?
por: Bagshaw, Sean M., et al.
Publicado: (2021)

Should We Prescribe More Protein to Critically Ill Patients?
por: Heyland, Daren K., et al.
Publicado: (2018)

Why do we need improved mobility technology?
por: Boninger, Michael L, et al.
Publicado: (2012)

Why Do We Need To Diversify the Microbial Sciences?
por: Torres, Alfredo G.
Publicado: (2021)

Glutamine in critically ill patients: is it a fundamental nutritional supplement?
por: Martins, Paulo
Publicado: (2016)

Gastrointestinal dysfunction in the critically ill: can we measure it?
por: Khadaroo, Rachel G, et al.
Publicado: (2008)

Advance care planning; we need to do it more, but it needs to be done differently
por: Heyland, Daren K.
Publicado: (2020)

Inotropes in goal-directed therapy: Do we need 'goals'?
por: Futier, Emmanuel, et al.
Publicado: (2010)

Do we really need standards in digital image management?
por: Ho, ELM
Publicado: (2008)

Protein in nutritional support: the newborn hero for the critically ill?
por: Oshima, Taku, et al.
Publicado: (2014)

Statins in the critically ill
por: De Loecker, Isabelle, et al.
Publicado: (2012)

Oral Nutrition during and after Critical Illness: SPICES for Quality of Care!
por: Fadeur, Marjorie, et al.
Publicado: (2020)

Do we need new trials of procalcitonin-guided antibiotic therapy?
por: Lisboa, Thiago, et al.
Publicado: (2018)

Why do we need better omics in the breast cancer care?
por: Gertych, Arkadiusz, et al.
Publicado: (2021)

Bio-electrical impedance analysis in critically ill patients: are we ready for prime time?
por: Myatchin, Ivan, et al.
Publicado: (2019)

Toward nutrition improving outcome of critically ill patients: How to interpret recent feeding RCTs?
por: Gunst, Jan, et al.
Publicado: (2023)

Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?
por: Askenazi, David J., et al.
Publicado: (2009)

Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019 (COVID-19): What do we know and what do we need to learn?
por: Jacobs, Jeffrey P., et al.
Publicado: (2022)

Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
por: Slattery, Jim, et al.
Publicado: (2020)

Real-time continuous glucose monitoring in children with critical illness - do we need it?
por: El-Nawawy, Ahmed
Publicado: (2015)

Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
por: Choi, Jonggi, et al.
Publicado: (2016)

Why do we need male contraceptives?
por: Cheng, C Yan, et al.
Publicado: (2013)

If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine
por: Ehrenstein, Michael R., et al.
Publicado: (2007)

Preoperative discussion with patients about delirium risk: are we doing enough?
por: Tomlinson, Judith H., et al.
Publicado: (2016)

Medical students find assessments stressful. Of course….but what do we do about it?
por: LeBlanc, Vicki R.
Publicado: (2014)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

High protein intake during the early phase of critical illness: yes or no?
por: Preiser, Jean-Charles
Publicado: (2018)

International recommendations for glucose control in adult non diabetic critically ill patients
por: Ichai, Carole, et al.
Publicado: (2010)

COVID-19: Risk factors for critical illness
por: Gao, Yadong
Publicado: (2020)

Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?
por: Pillai, Anish, et al.
Publicado: (2022)

Commentary: Do we really need specific recommendations for the use of one-piece hybrid devices?
por: Preventza, Ourania, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ljg334uqd98a1ncig3rneg8bu4